Sponsored Antibody halts triple-negative breast cancer in preclinical models January 30, 2026Vol.52 No.04By Hayley Kamin
Clinical Roundup Oral bacterium may promote breast cancer development and spread, Hopkins study finds January 30, 2026Vol.52 No.04
Drugs & Targets Trodelvy added to NCCN guidelines as preferred regimen option for first-line metastatic TNBC January 30, 2026Vol.52 No.04
Clinical Roundup Extracellular vesicles drug delivery mechanism could aid breast cancer treatment, UF study finds January 23, 2026Vol.52 No.03
Clinical Roundup Researchers find cell markers to track TNBC, Baylor College of Medicine study finds January 23, 2026Vol.52 No.03
Drugs & Targets Personalis Real-Time Variant Tracker identifies resistance mutations across several hundred clinically relevant hotspots January 23, 2026Vol.52 No.03
Clinical Roundup Breast cancer drug boosts leukemia treatment, OHSU-led study finds January 09, 2026Vol.52 No.1
Clinical Roundup Researchers decipher mechanism enabling breast cancer to metastasize to the brain January 09, 2026Vol.52 No.1
Drugs & Targets FDA grants Enhertu Breakthrough Therapy designation as post-neoadjuvant therapy for HER2+ early breast cancer January 09, 2026Vol.52 No.1
